Harrow Health Inc (NASDAQ:HROW)
| 20.28 Delayed Data As of Jun 09 |  -0.23 / -1.12%Today’s Change | 6.00 Today|||52-Week Range 28.25 | +37.40% Year-to-Date |
Latest HROW News | Press Releases
No recent news for Harrow Health Inc.
Today’s Trading
| Previous close | 20.51 |
| Today’s open | 20.48 |
| Day’s range | 20.16 - 20.72 |
| Volume | 9,819 |
| Average volume (3 months) | 438,221 |
| Market cap | $589.9M |
Data as of 3:59pm ET, 06/09/2023
Growth & Valuation
| Earnings growth (last year) | +25.72% |
| Earnings growth (this year) | +15.95% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +22.24% |
| P/E ratio | NM |
| Price/Sales | 4.58 |
| Price/Book | 21.22 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Microalliance Group ... | 0.00 | 0.00% |
| ---- | ||
| SVASinovac Biotech Ltd | 0.00 | 0.00% |
| TBPHTheravance Biopharma... | -0.14 | -1.30% |
Data as of 3:59pm ET, 06/09/2023
Financials
| Next reporting date | August 8, 2023 |
| EPS forecast (this quarter) | -$0.06 |
| Annual revenue (last year) | $88.6M |
| Annual profit (last year) | -$14.1M |
| Net profit margin | -15.90% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Nashville, Tennessee |
Forecasts
